Galectin Therapeutics
GALT
#8624
Rank
HK$1.03 B
Marketcap
HK$16.47
Share price
-8.23%
Change (1 day)
31.96%
Change (1 year)

Galectin Therapeutics (GALT) - Cash on Hand

Cash on Hand as of September 2024 : HK$0.21 Billion

According to Galectin Therapeutics's latest financial reports the company has HK$0.21 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galectin Therapeutics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31HK$0.14 B-53.01%
2021-12-31HK$0.30 B46.93%
2020-12-31HK$0.21 B-43.1%
2019-12-31HK$0.36 B472.16%
2018-12-31HK$64.62 M170.95%
2017-12-31HK$23.85 M-79.98%
2016-12-31HK$0.11 B-40.53%
2015-12-31HK$0.20 B-11.33%
2014-12-31HK$0.22 B177.78%
2013-12-31HK$81.33 M12.06%
2012-12-31HK$72.58 M46.09%
2011-12-31HK$49.68 M8.38%
2010-12-31HK$45.84 M2255.64%
2009-12-31HK$1.94 M-20.8%
2008-12-31HK$2.45 M-76.11%
2007-12-31HK$10.28 M-77.09%
2006-12-31HK$44.89 M29.67%
2005-12-31HK$34.62 M-58.37%
2004-12-31HK$83.18 M41.06%
2003-12-31HK$58.97 M293.59%
2002-12-31HK$14.98 M28.86%
2001-12-31HK$11.62 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$7.58 B 3,508.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.95 B 829.74%๐Ÿ‡บ๐Ÿ‡ธ USA